Science, Computers & Technology, Health Law, Antitrust & Trade Regulation

French Autorité de la Concurrence Fines Sanofi €40.6 Million for Denigrating Competing Generics"

by Simon Baxter, Frederic Depoortere, Ingrid Vandenborre, James Venit | Skadden, Arps, Slate, Meagher & Flom LLP on 5/21/2013

On May 14, 2013, the French Autorité de la Concurrence (Autorité) issued a decision imposing a fine of €40.6 million on French company Sanofi-Aventis France (Sanofi) for an abuse of dominance in the market for the...more

"Eye on Privacy" Newsletter - May 2013

by Wendell Bartnick, Cedric Burton, Caitlin Courtney, Wendy Devine, Tonia Klausner, Anna Pateraki, Tracy Shapiro, Gerard Stegmaier | Wilson Sonsini Goodrich & Rosati on 5/17/2013

In this issue: - FTC Issues New Guidance for Disclosures in Online Advertising - European Regulators Opine on "Purpose Limitation" Principle – What Constitutes "Compatible Use" in the Context of Big Data?...more

Par/Paddock Answers FTC Before Supreme Court

by Kevin E. Noonan | McDonnell Boehnen Hulbert & Berghoff LLP on 2/28/2013

Par PharmaceuticalPar/Paddock, one of the generic drug company defendants in FTC v. Actavis Inc. et al. (the "reverse payment" ANDA settlement case now before the Supreme Court) filed its reponsive brief last week. In it,...more

FTC Obtains Settlement From Cord Blood Bank In Data Theft Action

by BuckleySandler LLP on 2/14/2013

On February 5, a federal district court in California approved a settlement recently obtained by the FTC, which (i) requires a California-based firm that operates a cord blood bank to establish a comprehensive information...more

Two California Privacy Bills Introduced

by Jill Westmoreland | Loeb & Loeb LLP on 2/14/2013

California Assemblyman Isadore Hall introduced Assembly Bill 257 which addresses mobile privacy. The bill would codify many of the best practices proposed by the California Attorney General in her report titled “Privacy on...more

No Standing for Illegal Drugs: Third Circuit Limits Antitrust Standing for Foreign Drug Manufacturers Absent FDA Approval

by Bill Devinney | BakerHostetler on 2/7/2013

A Third Circuit panel recently ruled that a foreign drug manufacturer lacks antitrust standing when it could only sell its product in the United States through a distributor....more

The End of “Pay For Delay”?

by MoFo Tech on 1/15/2013

More brand-name drug companies have been paying their competitors to delay their efforts to bring generic versions of blockbuster pharmaceuticals to market....more

Health Care Legal News - November 28, 2012 • Volume 2, Number 10

by James M. Burns, Ralph Levy, Jr., Tatiana Melnik | Dickinson Wright on 12/3/2012

In This Issue: - Medicare Finalizes 2013 Physician Payment Schedule - Ohio Court Rules That A Court CAnnot Compel A Terminated Employee To Return PHI To The Former Employer - Insurer’s Antitrust Action AGainst...more

Health Care Legal News - October 25, 2012 • Volume 2, Number 9

by Dickinson Wright on 10/30/2012

In This Issue: - Five Core antitrust Principles For mergers of health insurers By: James M. Burns. On July 9, WellPoint and Amerigroup, two prominent health insurers, announced that they intended to merge in a...more

A Comprehensive Approach to Data Security

by Michael Volkov on 10/9/2012

Patrick Kellermann from LeClairRyan returns with a timely post on data security. When people hear “data security” they think technical jargon: firewalls, passwords, encryption, yada, yada, yada. They leave it up to...more

Another Loss for the Robinson-Patman Act

by Mintz Levin - Antitrust on 8/28/2012

In Drug Mart Pharmacy Corp. v. American Home Products Corp., 2012 U.S. Dist. LEXIS 11582 (E.D.N.Y. Aug. 16, 2012), Magistrate Judge Steven M. Gold gave the Robinson-Patman Act another drubbing. He granted summary judgment for...more

Healthcare Legal News - August 15, 2012 • Volume 2, Number 7

by Dickinson Wright on 8/16/2012

In This Issue: - Recent Cases Deal With Impact Of Termination Of Employed Physicians - Reimbursement News: Happy New Year!: Increase In Payments To Hospital Outpatient Departments and Ambulatory Surgical Centers -...more

Healthcare Legal News - June 21, 2012 • Volume 2, Number 5

by Dickinson Wright on 6/22/2012

In This Issue: - Self-Insurance Sham? One way that employers seek to control health plan costs is by self-insuring the plan. By self-insuring, an employer pays only the cost of claims plus an administrative fee...more

Federal Trade Commission Brings Two Enforcement Actions Related to Peer-to-Peer Networks

by Mintz Levin - Privacy & Security on 6/12/2012

The Federal Trade Commission (FTC) has brought two separate enforcement actions aimed at companies that improperly shared information over peer-to-peer (P2P) networks, putting, according to the FTC’s press release, the...more

New Seventh Circuit Decision Endorses Heightened Scrutiny of Experts at Class Certification Stage While Potentially Lowering the...

by Mintz Levin - Antitrust on 1/27/2012

In the health care antitrust world, the Federal Trade Commission (FTC) Evanston case, involving a retrospective attack on the consummated merger between Evanston Northwestern and Highland Park hospitals, is an important...more

ANDA Automatic Stay of FDA Approval Does Not Defeat Standing in Sham Litigation Antitrust Counterclaim

by Sheppard Mullin Richter & Hampton LLP on 9/21/2011

The District of Delaware recently denied a motion to dismiss an antitrust counterclaim in a patent infringement action in the wake of defendant Mylan, Inc. ("Mylan") having filed an Abbreviated New Drug Application ("ANDA")...more

European Commission Finds “Pay For Delay” Deals On The Decline In Europe But Pharma Sector Antitrust Scrutiny Continues

by King & Spalding on 7/12/2011

On July 6, 2011 the European Commission (Commission) published the results of its second monitoring exercise of patent settlements in the pharmaceutical sector (Second Monitoring Report). The Commission notes “with...more

FTC “Pomels” POM Wonderful and Other Companies for Making Allegedly False and Misleading Health Claims

by Mintz Levin - Antitrust on 10/8/2010

The Federal Trade Commission’s (FTC’s) recent enforcement initiatives on health claims may be heading for a showdown. On September 27, 2010, the FTC issued a particularly detailed 25-page administrative complaint charging POM...more

The ban on “pay to delay” pharma patent settlements: shaving health care costs, fighting anti-competition, and patents — all...

by Gregory P. Bufithis, Esq. on 7/2/2010

2 July 2010 – The U.S. House of Representatives has passed a measure banning patent settlements struck between brand-name and generic pharmaceutical companies to delay the release of generic drugs. The goal? To shave nearly...more

Home

Legal News

Find a Lawyer

Browse Subjects

Subscribe

Pro Services

For Reporters

Science, Computers & Technology › Health Law › Antitrust & Trade Regulation